Dr. Daniel Wallace Appointed to Lupus Therapeutics Board

New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics  Board of Directors.   This governing body, which includes lupus patients, family members and scientists,  provides strategic insight and financial oversight to help Lupus Therapeutics achieve its mission –accelerate new ways to diagnose and treat lupus.

The full press release is available on the Lupus Therapeutics website.

Read full Press Release

Recent Press Releases

Press Release
LRA Awards 2025 Lupus Insight Prize to Dr. Deepak Rao for Uncovering Key Drivers of Immune Imbalance in Lupus
June 25, 2025
The Lupus Research Alliance (LRA) proudly awarded the 2025 Lupus Insight Prize today to highly respected immunologist Deepak Rao,...
Press Release
Sports stars team up with NFL Champion Willie Colon to Drive Lupus Research
Super Bowl Champion Willie Colon Drives Discovery at 2025 Annual Lupus Research Alliance Golf Fundraiser
June 24, 2025
Over 300 attendees raised $450,000 to fuel research breakthroughs for those living with lupus   [caption id="attachment_14851" align="aligncenter" width="594"] Sports stars...
Press Release
LRA Launches Lupus Nexus Foundational Analyses
Lupus Research Alliance Spearheads Groundbreaking Lupus Nexus Foundational Analyses to Accelerate Personalized Lupus Treatments and a Cure
May 20, 2025
Largest private funder of lupus research initiates major efforts to integrate numerous biospecimen analyses with clinical data and patient-reported outcomes...